BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 21719401)

  • 1. Pityriasis rubra pilaris with prominent acantholytic dyskeratosis.
    Battistella M; Pages C; Demongeot C; Cavelier-Balloy B; Bagot M; Viguier M
    Eur J Dermatol; 2011; 21(5):796-7. PubMed ID: 21719401
    [No Abstract]   [Full Text] [Related]  

  • 2. Case of pityriasis rubra pilaris with focal acantholytic dyskeratosis.
    Itoh Y; Asahina A; Kanbe M; Ito K; Nakagawa H
    J Dermatol; 2018 Sep; 45(9):e258-e259. PubMed ID: 29512184
    [No Abstract]   [Full Text] [Related]  

  • 3. Pityriasis rubra pilaris.
    White KL
    Dermatol Online J; 2003 Oct; 9(4):6. PubMed ID: 14594579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pityriasis rubra pilaris. Case reports and review of the literature].
    Artik S; Megahed M; Ruzicka T
    Hautarzt; 2003 Sep; 54(9):858-63. PubMed ID: 12955264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pityriasis rubra pilaris triggered by photodynamic therapy with response to tumor necrosis factor α-blocking agents and acitretin.
    López-Ferrer A; Dalmau J; Fernández-Figueras MT; Puig L
    Cutis; 2014 Mar; 93(3):E6-7. PubMed ID: 24738108
    [No Abstract]   [Full Text] [Related]  

  • 6. Focal acantholytic dyskeratosis occurring in pityriasis rubra pilaris.
    Hoover WD; Maize JC
    Am J Dermatopathol; 1990 Jun; 12(3):321-3. PubMed ID: 2393436
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of pityriasis rubra pilaris with pimecrolimus cream 1%.
    Gregoriou S; Argyriou G; Christofidou E; Vranou A; Rigopoulos D
    J Drugs Dermatol; 2007 Mar; 6(3):340-2. PubMed ID: 17373199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of erythrodermic pityriasis rubra pilaris with acitretin.
    Atzori L; Zanniello R; Lappi A; Pinna AL; Ferreli C; Rongioletti F; Pilloni L
    Dermatol Ther; 2018 Sep; 31(5):e12694. PubMed ID: 30230135
    [No Abstract]   [Full Text] [Related]  

  • 9. Cyclical Inguinal Keratoderma: A New Clinical Entity or a Variant of Pityriasis Rubra Pilaris?
    Kumarasinghe SP; Kim J; Yu L; Papadimitriou J
    Australas J Dermatol; 2016 Aug; 57(3):243-4. PubMed ID: 27469485
    [No Abstract]   [Full Text] [Related]  

  • 10. Pityriasis rubra pilaris with polyarthritis treated with adalimumab.
    Chiu HY; Tsai TF
    J Am Acad Dermatol; 2013 Jan; 68(1):187-8. PubMed ID: 23244382
    [No Abstract]   [Full Text] [Related]  

  • 11. Widespread erythematous skin eruption.
    Généreux AD; Wetter DA
    J Fam Pract; 2017 Mar; 66(3):181-183. PubMed ID: 28249057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pityriasis rubra pilaris: failure of combination treatment with acitretin and infliximab.
    Lu R; George SJ; Hsu S
    Dermatol Online J; 2006 May; 12(4):18. PubMed ID: 17083873
    [No Abstract]   [Full Text] [Related]  

  • 13. Pityriasis rubra pilaris with epidermolytic hyperkeratosis.
    Doughty LE; Wells MJ; Stetson CL
    J Drugs Dermatol; 2008 Oct; 7(10):978-9. PubMed ID: 19112765
    [No Abstract]   [Full Text] [Related]  

  • 14. [Erythroderma after corticosteroid withdrawal in papulosquamous dermatosis in children. Diagnosis: pityriasis rubra pilaris, classic juvenile type].
    Terheyden P; Hofmann UB; Hamm H; Bröcker EB
    Hautarzt; 2001 Nov; 52(11):1058-61. PubMed ID: 11757463
    [No Abstract]   [Full Text] [Related]  

  • 15. Pityriasis rubra pilaris, type 1.
    Booth AV; Ma L
    Dermatol Online J; 2005 Dec; 11(4):9. PubMed ID: 16403381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late onset pityriasis rubra pilaris type IV treated with low-dose acitretin.
    Mota F; Carvalho S; Sanches M; Selores M
    Acta Dermatovenerol Alp Pannonica Adriat; 2016; 25(1):15-7. PubMed ID: 27014774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circumscribed pityriasis rubra pilaris type IV.
    Caldarola G; Zampetti A; De Simone C; Massi G; Amerio P; Feliciani C
    Clin Exp Dermatol; 2007 Jul; 32(4):471-2. PubMed ID: 17239092
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical improvement of pityriasis rubra pilaris with combination etanercept and acitretin therapy.
    Davis KF; Wu JJ; Murase JE; Rosenberg FR; Sorenson EP; Meshkinpour A
    Arch Dermatol; 2007 Dec; 143(12):1597-9. PubMed ID: 18087024
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of refractory adult-onset pityriasis rubra pilaris with TNF-alpha antagonists: a case series.
    Garcovich S; Di Giampetruzzi AR; Antonelli G; Garcovich A; Didona B
    J Eur Acad Dermatol Venereol; 2010 Aug; 24(8):881-4. PubMed ID: 20002243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response of juvenile circumscribed pityriasis rubra pilaris to topical tazarotene treatment.
    Karimian-Teherani D; Parissa M; Tanew A
    Pediatr Dermatol; 2008; 25(1):125-6. PubMed ID: 18304175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.